Tower Research Capital LLC (Trc) Morphic Holding, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.07 Billion
- Q1 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 188 shares of MORF stock, worth $6,405. This represents 0.0% of its overall portfolio holdings.
Number of Shares
188
Previous 4,243
95.57%
Holding current value
$6,405
Previous $122,000
95.08%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding MORF
# of Institutions
142Shares Held
37.9MCall Options Held
13.5KPut Options Held
190K-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.69MShares$160 Million0.42% of portfolio
-
Wellington Management Group LLP Boston, MA4.02MShares$137 Million0.03% of portfolio
-
Black Rock Inc. New York, NY3.28MShares$112 Million0.0% of portfolio
-
State Street Corp Boston, MA2.67MShares$90.8 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.52MShares$86 Million0.01% of portfolio
About Morphic Holding, Inc.
- Ticker MORF
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,477,100
- Market Cap $1.31B
- Description
- Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...